Company: INSP
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001140361-25-009249
Chunk: 18

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 18
---
 firm engaged for the purpose of preparing or issuing an audit report or related work or performing other audit, review, or attest services for us; |

| • | discussing with our independent auditor any audit problems or difficulties and management’s response; |

| • | pre-approving all audit and non-audit services provided to us by our independent auditor (other than those provided pursuant to appropriate preapproval policies established by the committee or exempt from such requirement under SEC rules); |

| • | reviewing and discussing our annual and quarterly financial statements with management and our independent registered public accounting firm; |

| • | discussing and overseeing our policies with respect to risk assessment and risk management, including major financial risk exposures and the steps management has taken to monitor and control such exposures; |

| • | overseeing our information security and technology risks, including information security, cybersecurity, and related risk management programs; |

| • | reviewing management’s use of sustainability measures and metrics, as well as other non-GAAP measures and metrics, and reviewing in particular how these measures are used to evaluate performance, whether they are consistently prepared and presented, what disclosure controls and procedures relating to these measures are in place, and how such measures are disclosed; and |

| Inspire Medical Systems, Inc. |     | 17 |     | 2025 Proxy Statement |

TABLE OF CONTENTS

| CORPORATE GOVERNANCE |

| • | overseeing, and annually reviewing, procedures for the receipt, retention, and treatment of complaints received by us regarding accounting, internal accounting controls, or auditing matters, and for the confidential and anonymous submission by our employees of concerns regarding questionable accounting or auditing matters. |

The Audit Committee may delegate its authority under its charter to one or more subcommittees as it deems appropriate from time to time. The Audit Committee has the authority to engage independent legal, accounting, and other advisors as it deems necessary or appropriate to assist in carrying out its responsibilities. We must provide appropriate funding for payment of reasonable compensation to any advisor retained by the Audit Committee. Our Audit Committee currently consists of Ms. Burks, Ms. Garinois-Melenikiotou, Mr. McCormick, and Mr. Mead, with Mr. McCormick serving as chair. All current members of the committee served on the committee for all of fiscal 2024, except for Ms. Burks who was appointed in February 2025. All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the NYSE. Our Board of Directors has affirm